MedPath

U.S. Health Officials Start First Clinical Trial With Gilead Sciences' Experimental Coronavirus Treatment @themotleyfool #stocks $GILD

A U.S. COVID-19 patient was treated with remdesivir, marking the first such treatment in the U.S. A clinical trial has begun, with the first participant being a quarantined American from the Diamond Princess. Remdesivir's effectiveness remains uncertain without comparative data. Health officials urge public preparation for significant disruptions due to COVID-19 spread.


Reference News

U.S. Health Officials Start First Clinical Trial With Gilead Sciences' Experimental Coronavirus Treatment @themotleyfool #stocks $GILD

A U.S. COVID-19 patient was treated with remdesivir, marking the first such treatment in the U.S. A clinical trial has begun, with the first participant being a quarantined American from the Diamond Princess. Remdesivir's effectiveness remains uncertain without comparative data. Health officials urge public preparation for significant disruptions due to COVID-19 spread.

© Copyright 2025. All Rights Reserved by MedPath